ARTV
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. (ARTV) has 10 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 14, 2026.
The most active filer is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. with 8 filings. Insiders have net bought $82.7M over the trailing 6 months. The largest single insider purchase in this window was $75.0M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on May 11, 2026.
- Industry:Biotechnology
- CEO:Fred Aslan
- Employees:96
- HQ:San Diego, CA, US
- IPO:2024-07-19
Insider Buying
$83.1M
reported purchases (SEC code P)
Insider Selling
$478K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$245.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 15,102 | $135K | Jul 14 | SEC ↗ | |
| Director, 10% Owner | Purchase | 6,552 | $59K | Jul 14 | SEC ↗ | |
| Director, 10% Owner | Purchase | 31,000 | $275K | Jun 29 | SEC ↗ | |
| Director, 10% Owner | Purchase | 1,876 | $17K | Jun 29 | SEC ↗ | |
| Director, 10% Owner | Purchase | 479,039 | $3.3M | Jun 11 | SEC ↗ | |
| Director, 10% Owner | Purchase | 103 | $721 | Jun 11 | SEC ↗ | |
| Director, 10% Owner | Purchase | 548,580 | $4.3M | Jun 11 | SEC ↗ | |
Raymon HeatherFirst filing | SVP, Research and Development | Sale | 3,095 | $28K | May 20 | SEC ↗ |
Horan ChristopherFirst filing | Chief Tech Operations Officer | Sale | 7,002 | $63K | May 20 | SEC ↗ |
Bush JenniferFirst filing | COO, CLO, Compliance Officer | Sale | 8,790 | $79K | May 20 | SEC ↗ |
Banerjee SubhashisFirst filing | Chief Medical Officer | Sale | 7,037 | $63K | May 20 | SEC ↗ |
Aslan FredFirst filing | Chief Executive Officer | Sale | 27,116 | $244K | May 20 | SEC ↗ |
| Director, 10% Owner | Purchase | 6,510,416 | $75.0M | May 13 | SEC ↗ |
Related companies
Artiva Biotherapeutics, Inc. is in the Healthcare sector.